Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: magnitude and predictability of interindividual differences
- PMID: 7408410
- DOI: 10.1038/clpt.1980.195
Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: magnitude and predictability of interindividual differences
Abstract
The purposes of this investigation were to determine the magnitude of inter- and intraindividual variations in the relationship between heparin concentration and anticoagulant effect in normal adults, and to determine whether these variations are asociated with, and therefore predictable from, certain physiologic characteristics of individual subjects. Citrated plasma was obtained from 12 men and 5 women, 21 to 35 yr old. Heparin was added to the plasma to yield concentrations of 0.05 to 1.0 U/ml and the activated partial thromboplastin time (APTT) was determined. These studies were repeated once or twice over 65 days. Baseline APTT values (i.e., ATPP without added heparin) ranged from 25.6 to 36.2 sec and the hematocrit ranged from 39% to 50%. Both measures showed little intrasubject variation on the same day or on different days. There was an excellent linear relationship between In APTT and heparin concentration in the 0.05- to 0.8-U/ml range (r2 > 0.987 in all cases). The slope value for this relationship ranged from 1.51 to 3.88 ml/U and these interindividual differences were well reproducible on repeated testing. Women had lower hematocrits (p < 0.05) and higher slope values (p < 0.01) than men. Multiple linear regression analysis revealed a linear relationship between observed slope values and slope values calculated as a function of both hematocrit and baseline APTT. Age, weight, and the concentrations of various plasma proteins did not contribute significantly to the predictability of the slope. A multiple linear regression equation with hematocrit and baseline APtt as independent variables yielded a multiple correlation coefficient of 0.875 (p < 0.01). Thus, it may be possible to predict the APTT value produced by a given concentration of heparin in an individual subject from the subject's baseline APTT and hematocrit.
Similar articles
-
Intersubject variability in the anticoagulant response to heparin in vitro.Eur J Clin Pharmacol. 1982;21(6):491-7. doi: 10.1007/BF00542044. Eur J Clin Pharmacol. 1982. PMID: 6176454
-
Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences.Clin Pharmacol Ther. 1982 Oct;32(4):503-16. doi: 10.1038/clpt.1982.195. Clin Pharmacol Ther. 1982. PMID: 7116766
-
Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasma.J Pharm Sci. 1983 Oct;72(10):1141-6. doi: 10.1002/jps.2600721008. J Pharm Sci. 1983. PMID: 6644559
-
Monitoring unfractionated heparin with the aPTT: time for a fresh look.Thromb Haemost. 2006 Nov;96(5):547-52. Thromb Haemost. 2006. PMID: 17080209 Review.
-
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations.Semin Thromb Hemost. 2017 Apr;43(3):253-260. doi: 10.1055/s-0036-1581128. Epub 2016 Jun 6. Semin Thromb Hemost. 2017. PMID: 27272964 Review.
Cited by
-
Assay-dependent kinetics of heparin: evidence for rapid in vivo activation of heparin.Br J Clin Pharmacol. 1983 Dec;16(6):677-82. doi: 10.1111/j.1365-2125.1983.tb02240.x. Br J Clin Pharmacol. 1983. PMID: 6661353 Free PMC article.
-
New method to predict patients' intravenous heparin dose requirements.J Gen Intern Med. 1996 Mar;11(3):168-73. doi: 10.1007/BF02600270. J Gen Intern Med. 1996. PMID: 8667094
-
Intersubject variability in the anticoagulant response to heparin in vitro.Eur J Clin Pharmacol. 1982;21(6):491-7. doi: 10.1007/BF00542044. Eur J Clin Pharmacol. 1982. PMID: 6176454
-
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002. Clin Pharmacokinet. 1981. PMID: 7032803 Review. No abstract available.
-
Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability.Clin Pharmacokinet. 1998 Apr;34(4):323-33. doi: 10.2165/00003088-199834040-00005. Clin Pharmacokinet. 1998. PMID: 9571304 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical